Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

How This Fund’s Bets on Allergan, Inc. (AGN), Charter Communications, Inc. (CHTR) & Two Other Stocks Pay Off?

Oskie Capital Management is a New York-based hedge fund founded by David M. Markowitz. Oskie Capital’s equity portfolio has a value of $182.42 million as of the end of September, compared to $166.83 million at the end of June. The fund returned 13.80% from its 17 long positions in companies which have a market cap of at least $1 billion, according to our calculations.

In a time when investors are not happy with the $3 trillion hedge fund industry due to losses and sloppy performance, it’s important to pay attention to the right moves of the smart money to beat the market. Our research has proven that hedge funds post positive returns from their long positions in companies having a market capitalization of at least $1 billion. For instance, there were 659 hedge funds in our database that had at least five non-microcap stocks in their 13F portfolio. These hedge funds’ long portfolio managed to deliver an average return of 8.3% during the third quarter, whereas S&P 500 ETFs returned only 3.3%.

With this in mind, let’s take a closer look at four of Oskie Capital’s top bets, including Allergan, Inc. (NYSE:AGN), Charter Communications, Inc. (NASDAQ:CHTR), TransDigm Group Incorporated (NYSE:TDG), and KAR Auction Services Inc (NYSE:KAR).

computers, work,

Tonis Valing /

Oskie Capital Management sold 43% of its stake in Allergan, Inc. (NYSE:AGN) in the third quarter, ending the period with 44,409 shares valued at about $10.22 million. The investment seems to have disappointed as the stock inched down by 0.3% last quarter. During the second quarter, the number of funds from our database long Allergan slid to 131 from 170. More specifically, Third Point was the largest shareholder of Allergan, Inc. (NYSE:AGN), with a stake worth $1.13 billion reported as of the end of June. Trailing Third Point was Paulson & Co, which amassed a stake valued at $912.4 million. Icahn Capital LP, Elliott Management, and Elliott Management also held valuable positions in the company.

Follow Allergan Inc (NYSE:AGN)
Trade (NYSE:AGN) Now!

Oskie Capital Management cut its stake in Charter Communications, Inc. (NASDAQ:CHTR) by 17% to 53,143 shares worth $14.35 million during the third quarter, as the stock advanced by 18.1% in the same period. Overall, the number of funds from our database long Charter Communications went up by 36 to 134 during the second quarter. Among these funds,  Warren Buffett’s Berkshire Hathaway had the most valuable position in Charter Communications, Inc. (NASDAQ:CHTR), worth close to $2.14 billion at the end of June. On Berkshire Hathaway’s heels was Lone Pine Capital, managed by Stephen Mandel, which held a $1.10 billion position. Remaining hedge funds and institutional investors that are bullish included Chase Coleman’s Tiger Global Management LLC, Eric W. Mandelblatt’s Soroban Capital Partners and John Armitage’s Egerton Capital Limited.

Follow Charter Communications Inc (NASDAQ:CHTR)
Trade (NASDAQ:CHTR) Now!

DOWNLOAD FREE REPORT: Warren Buffett's Best Stock Picks

Let Warren Buffett, George Soros, Steve Cohen, and Daniel Loeb WORK FOR YOU.

If you want to beat the low cost index funds by 19 percentage points per year, look no further than our monthly newsletter.In this free report you can find an in-depth analysis of the performance of Warren Buffett's entire historical stock picks. We uncovered Warren Buffett's Best Stock Picks and a way to for Buffett to improve his returns by more than 4 percentage points per year.

Bonus Biotech Stock Pick: You can also find a detailed bonus biotech stock pick that we expect to return more than 50% within 12 months.
Subscribe me to Insider Monkey's Free Daily Newsletter
This is a FREE report from Insider Monkey. Credit Card is NOT required.